On March 22nd, 60 Minutes highlighted the Dog Aging Project co-founded by multiple grantee and Cristofalo Award winner Matt Kaeberlein, PhD, and grantee Daniel Promislow, DPhil.
Dr. Kaeberlein shared insights on the Dog Aging Project’s potential as it explores the effects of different therapeutics, soon to include Rapamycin, on canine longevity and healthspan, helping to advance our understanding of aging and its potential implications on human healthspan.
Dr. Kaeberlein is a 2006 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, and a 2007 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient. He is also the 2011 recipient of AFAR’s Vincent Cristofalo Rising Star Award in Aging Research.
Dr. Promislow is a 1998 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient and a 2010 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient.
For more expert-backed insights on the link between human aging and canine longevity, see our Live Better Longer Webinar on The Dog Aging Project here.
Watch the 60 Minute segment here.
Read a companion CBS article here.
